Akeso's first bispecific ADC enters clinical trials, advancing ‘IO+ADC’ 2.0 strategy

Akeso's first bispecific ADC enters clinical trials, advancing ‘IO+ADC’ 2.0 strategy

The Trop2/Nectin4 bispecific drug reinforces Akeso’s pipeline of next-generation oncology treatments.
ADC drops anti-dumping case of Vietnamese steel

ADC drops anti-dumping case of Vietnamese steel

After a year of thorough investigation into the anti-dumping and anti-subsidisation case of Vietnamese coiled steel rod, the Australian Anti-Dumping Commission (ADC) has closed the matter.